clopidogrel has been researched along with 3,3-dimethylbutan-1-ol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T | 1 |
1 other study(ies) available for clopidogrel and 3,3-dimethylbutan-1-ol
| Article | Year |
|---|---|
Choline and trimethylamine N-oxide impair metabolic activation of and platelet response to clopidogrel through activation of the NOX/ROS/Nrf2/CES1 pathway.
Topics: Acetylcysteine; Activation, Metabolic; Animals; Choline; Clopidogrel; Male; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species | 2023 |